ArTara Therapeutics
New York, US · Founded 2017 · Delaware corporation
Founders & leadership
DS
David SmithExecutive
RM
Randall MarshallExecutive
JS
Jesse SheffermanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 1 round · 2017
▶$4.2MraisedJan 2018 · 2 investors · PharmaceuticalsRule 506(b)
▶$4.2MraisedJan 2018 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David SmithExecutive Officer
- Jesse SheffermanExecutive Officer, Director
- Randall MarshallExecutive Officer, Director
- Amount sold
- $4.2M
- Minimum investment
- $25K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has ArTara Therapeutics raised?
- ArTara Therapeutics has disclosed $4.2M raised across 1 round.
- Where is ArTara Therapeutics headquartered?
- ArTara Therapeutics is headquartered in New York, US.